Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
11.16
+0.20 (1.82%)
Jun 5, 2025, 4:00 PM - Market closed

Syndax Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 11 professional analysts, the 12-month price target for Syndax Pharmaceuticals stock ranges from a low of $17 to a high of $51. The average analyst price target of $35.91 forecasts a 221.77% increase in the stock price over the next year.

Price Target: $35.91 (+221.77%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $17 $35.91 $37 $51
Change +52.33% +221.77% +231.54% +356.99%
* Price targets were last updated on May 6, 2025.

Analyst Ratings

The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 777788
Buy 222222
Hold 111111
Sell 000000
Strong Sell 000000
Total 101010101111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Scotiabank
Scotiabank
Hold
Maintains
$16$17
Hold Maintains $16$17 +52.33% May 6, 2025
Guggenheim
Guggenheim
Strong Buy
Reiterates
$32
Strong Buy Reiterates $32 +186.74% May 6, 2025
JP Morgan
JP Morgan
Buy
Maintains
$39$41
Buy Maintains $39$41 +267.38% Mar 20, 2025
JP Morgan
JP Morgan
Buy
Maintains
$35$39
Buy Maintains $35$39 +249.46% Mar 4, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$45$42
Strong Buy Maintains $45$42 +276.34% Mar 4, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
124.74M
from 23.68M
Increased by 426.77%
Revenue Next Year
247.37M
from 124.74M
Increased by 98.31%
EPS This Year
-3.75
from -3.72
EPS Next Year
-2.69
from -3.75
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
1.52M139.71M--23.68M124.74M247.37M370.41M
Revenue Growth
-9,109.56%---426.77%98.31%49.74%
EPS
-1.870.46-2.46-2.98-3.72-3.75-2.69-1.63
EPS Growth
--------
Forward PE
--------
No. Analysts
-----141411
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 161.9M 305.0M 491.6M
Avg 124.7M 247.4M 370.4M
Low 81.3M 174.4M 239.3M

Revenue Growth

Revenue Growth 20252026202720282029
High
583.9%
144.5%
98.7%
Avg
426.8%
98.3%
49.7%
Low
243.5%
39.8%
-3.3%

EPS Forecast

EPS 20252026202720282029
High -2.76 -0.92 -0.89
Avg -3.75 -2.69 -1.63
Low -4.07 -3.25 -2.15

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.